| Website | bdc.ca/en/busines... |
| Phone | 877-232-2269 |
| Employees | |
| Founded | 2/06 |
“BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the company’s development cycle, from seed through expansion, with a focus on technology-based businesses that have high growth potential and that are positioned to become dominant players in their markets.
BDC Venture Capital has been involved in venture capital since 1975 and has to date invested in more than 400 companies involved in the areas of Life Sciences, Telecommunications, Information Technology and Advanced Technologies.” (Source: BDC)
| Company | Date | Round | Size | Participants |
| Allostera Pharma | 7/09 | Series C | $15.4M | 4 |
| Covarity | 5/09 | Unattributed | $3M | 4 |
| Teradici | 4/09 | Series C | $17M | 6 |
| OneChip Photonics | 3/09 | Series A | $19.5M | 4 |
| OneChip Photonics | 3/09 | Series B | $15.3M | 4 |
| Apparent Networks | 2/09 | Series C | $12M | 4 |
| Wavesat | 2/09 | Unattributed | $9.5M | 3 |
| Vaprema | 12/08 | Series B | $17.2M | 4 |
| Sutus | 10/08 | Unattributed | $4.5M | 3 |
| Neuralitic Systems | 10/08 | Series A | $7M | 3 |
| Natrix Separations | 9/08 | Series B | $19M | 4 |
| Diablo Technologies | 7/08 | Series B | $15M | 3 |
| Inimex Pharmaceuticals | 6/08 | Series B | $22M | 8 |
| Sutus | 6/08 | Unattributed | $4.97M | 2 |
| Osprey Pharmaceuticals USA | 5/08 | Series A | $11M | 6 |
| Zeugma Systems Inc. | 12/07 | Series B | $22.5M | 6 |
| CELLFOR | 11/07 | Unattributed | $24.5M | 3 |
| Vaprema | 11/07 | Unattributed | $23.1M | 4 |
| Vantrix | 9/07 | Series B | $12M | 5 |
| Radian6 | 5/07 | Series A | $4M | 3 |
| EQO | 4/07 | Series A | $3.5M | 2 |
| EQO | 4/07 | Series B | $9M | 3 |
| iWeb Technologies | 2/07 | Debt | C$4.5M | 1 |
| iWeb Technologies | 6/06 | Debt | C$1.35M | 1 |
| Inimex Pharmaceuticals | 7/04 | Series A | $4.5M | 3 |
| Trigence | 3/04 | Series A | $5.5M | 1 |
| GridPoint | Series A | $8M | 2 | |
| Kleer | Series A | $30M | 5 |
